Reports Q2 revenue $591.19M, consensus $578.82M. Reports Q2 adjusted EBITDA of $73.2M compared to $74.6M in 2023.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMED:
- Amedisys Releases Q2 Supplemental Financial Slides
- Birkenstock upgraded, Charter initiated: Wall Street’s top analyst calls
- William Blair downgrades Amedisys on tighter takeover spread
- Amedisys, UnitedHealth to divest home health care centers to VitalCaring
- Amedisys downgraded to Market Perform from Outperform at William Blair